标题
Advances in developing noncovalent small molecules targeting Keap1
作者
关键词
-
出版物
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages 103800
出版商
Elsevier BV
发表日期
2023-10-17
DOI
10.1016/j.drudis.2023.103800
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advances and challenges in therapeutic targeting of NRF2
- (2023) Albena T. Dinkova-Kostova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N′-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction
- (2023) Dhulfiqar.Ali Abed et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Macrocycles in Drug Discovery─Learning from the Past for the Future
- (2023) Diego Garcia Jimenez et al. Journal of Medicinal Chemistry
- Fragment-Based Discovery of Azocyclic Alkyl Naphthalenesulfonamides as Keap1-Nrf2 Inhibitors for Acute Lung Injury Treatment
- (2023) Jianyu Yan et al. Journal of Medicinal Chemistry
- Omaveloxolone (SkyclarysTM) for patients with Friedreich’s ataxia
- (2023) Sharadha Dayalan Naidu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor
- (2023) Kazuki Otake et al. ACS Medicinal Chemistry Letters
- A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
- (2023) Yi Sun et al. Redox Biology
- Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1
- (2023) Mingming Qi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
- (2023) Ziquan Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Minimizing the DILI potential of carboxylic acid-containing drugs: a perspective
- (2023) Lars Weidolf et al. MEDICINAL CHEMISTRY RESEARCH
- Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo
- (2023) Se Yong Park et al. Redox Biology
- Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction
- (2022) Fabio Begnini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein–Protein Interaction Inhibitors with an Alternative Binding Mode
- (2022) Nikolaos Georgakopoulos et al. JOURNAL OF MEDICINAL CHEMISTRY
- The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity
- (2022) Laura Casares et al. Redox Biology
- Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N′-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction
- (2022) Sumi Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Crystallography-Guided Optimizations of the Keap1–Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides
- (2022) Guodong Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis
- (2022) Tatsuya Ogawa et al. Antioxidants
- Design, synthesis and evaluation of novel small molecules acting as Keap1-Nrf2 protein-protein interaction inhibitors
- (2022) Yunfeng Sun et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
- (2022) Enrique Crisman et al. MEDICINAL RESEARCH REVIEWS
- Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
- (2022) Dilip Narayanan et al. Journal of Medicinal Chemistry
- Design and characterization of a heterobifunctional degrader of KEAP1
- (2022) Hao Chen et al. Redox Biology
- Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory Pathway
- (2022) Fengqin Wang et al. ACS Pharmacology & Translational Science
- Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
- (2021) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue
- (2021) Dmitry M. Hushpulian et al. Frontiers in Aging Neuroscience
- Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism
- (2021) Yuta Horie et al. Communications Biology
- Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation
- (2021) Dhulfiqar Ali Abed et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
- (2021) Zhenyi Hu et al. CHEMBIOCHEM
- Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously
- (2021) Li Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation
- (2021) Jieli Wei et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
- (2021) Henry Jay Forman et al. NATURE REVIEWS DRUG DISCOVERY
- Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
- (2021) Le Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein−Protein Interaction
- (2021) David Norton et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction
- (2020) Dhulfiqar Ali Abed et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors
- (2020) Phillip R. Lazzara et al. ACS Medicinal Chemistry Letters
- Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
- (2020) Yong Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
- (2020) Liam Baird et al. MOLECULAR AND CELLULAR BIOLOGY
- Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction
- (2020) Jesus M. Ontoria et al. ACS Medicinal Chemistry Letters
- Acyl glucuronide reactivity in perspective
- (2020) Peter R. Bradshaw et al. DRUG DISCOVERY TODAY
- A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions
- (2020) Mengchen Lu et al. Redox Biology
- Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
- (2020) Yi Sun et al. BIOORGANIC CHEMISTRY
- Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors
- (2020) Hai-Shan Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- On the Clinical Pharmacology of Reactive Oxygen Species
- (2020) Ana I. Casas et al. PHARMACOLOGICAL REVIEWS
- Bardoxolone conjugation enables targeted protein degradation of BRD4
- (2020) Bingqi Tong et al. Scientific Reports
- Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions
- (2020) Meng-Chen Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mining Natural Products for Macrocycles to Drug Difficult Targets
- (2020) Fabio Begnini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis
- (2019) Sudhir Kumar Yadav et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands
- (2019) Maxwell D. Cummings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction
- (2019) Tom D. Heightman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity
- (2019) Meng-Chen Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comparative Assessment Study of Known Small-Molecule Keap1−Nrf2 Protein–Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity
- (2019) Kim T. Tran et al. JOURNAL OF MEDICINAL CHEMISTRY
- CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation
- (2019) Meng-Chen Lu et al. Redox Biology
- Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury
- (2019) Qiaoyan Hui et al. FREE RADICAL BIOLOGY AND MEDICINE
- Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability
- (2019) Phillip R. Lazzara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators
- (2019) Bin Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists.
- (2018) Martin A Bewley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
- (2018) Mengchen Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
- (2018) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
- (2018) Antonio Cuadrado et al. PHARMACOLOGICAL REVIEWS
- Modulating NRF2 in Disease: Timing Is Everything
- (2018) Matthew Dodson et al. Annual Review of Pharmacology and Toxicology
- Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors
- (2018) Benjamin G. Richardson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming
- (2018) David Olagnier et al. Nature Communications
- Identification of Novel Protein Targets of Dimethyl Fumarate Modification in Neurons and Astrocytes Reveals Actions Independent of Nrf2 Stabilization
- (2018) Gerardo G. Piroli et al. MOLECULAR & CELLULAR PROTEOMICS
- Transcriptional Regulation by Nrf2
- (2017) Claudia Tonelli et al. ANTIOXIDANTS & REDOX SIGNALING
- Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
- (2016) Thomas G. Davies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
- (2016) Ulf Schulze-Topphoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
- (2016) Megan M. Blewett et al. Science Signaling
- Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors
- (2016) Meng-Chen Lu et al. ACS Medicinal Chemistry Letters
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
- (2016) Megan M. Blewett et al. Science Signaling
- Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
- (2016) Luca Prosperini et al. Therapeutics and Clinical Risk Management
- An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis
- (2016) Meng-Chen Lu et al. Scientific Reports
- Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways
- (2015) Joanna D. Wardyn et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
- (2015) Atul D. Jain et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor
- (2015) Xia Wen et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling
- (2015) Angelika F. Winkel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure–Activity and Structure–Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1–Nrf2 Protein–Protein Interaction Inhibitor
- (2015) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro
- (2015) Melanie S. Brennan et al. PLoS One
- Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
- (2014) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
- (2014) Eric Jnoff et al. ChemMedChem
- Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
- (2014) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
- (2014) Anne Cleasby et al. PLoS One
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
- (2013) Douglas Marcotte et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
- (2013) Longqin Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Up-down Regulation of HO-1 and iNOS Gene Expressions by Ethyl Pyruvate via Recruiting p300 to Nrf2 and Depriving It from p65
- (2013) Seung-Woo Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR
- (2011) Mark M. Yore et al. PLoS One
- Suppression of NF-κB signaling by KEAP1 regulation of IKKβ activity through autophagic degradation and inhibition of phosphorylation
- (2010) Jeong-Eun Kim et al. CELLULAR SIGNALLING
- Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds
- (2009) A.Kenneth MacLeod et al. CARCINOGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now